SEC Form 4 · accession 0001104659-18-058453
Y-mAbs Therapeutics, Inc. · YMAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Moller San Pedro Claus Juan
Officer — Chief Executive Officer · Director
Period of report
Sep 25, 2018
Accepted (ET)
Sep 25, 2018 · 4:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001722964
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 25, 2018 | P | 15,625 | $16.00 | A | 872,928 | D | |
| Common StockF1 | Sep 25, 2018 | P | 15,625 | $16.00 | A | 872,928 | I | By CM Holding 2015 ApS |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1CM Holding 2015 ApS is Reporting Person's personal holding company of which Reporting Person is the sole owner and as such Reporting Person has sole voting and dispositive power with respect to such shares.